ProfileGDS4718 / 236123_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 53% 53% 54% 55% 66% 48% 47% 53% 63% 55% 52% 58% 47% 46% 45% 51% 58% 54% 47% 56% 51% 66% 52% 59% 63% 54% 63% 51% 56% 50% 44% 54% 64% 56% 48% 52% 49% 51% 56% 56% 58% 49% 56% 48% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6809153
GSM549102patient 115, normal, homogenized [OPG study]5.6827353
GSM549104patient 119, normal, homogenized [OPG study]5.743154
GSM549108patient 138, normal, homogenized [OPG study]5.8224655
GSM549119patient 077, normal, homogenized [OPG study]6.5050366
GSM549133patient 032, cancer, homogenized [OPG study]5.3336348
GSM549139patient 042, cancer, homogenized [OPG study]5.3347647
GSM549099patient 107, normal, homogenized [OPG study]5.7102953
GSM549109patient 139, normal, homogenized [OPG study]6.3232463
GSM549110patient 046, normal, homogenized [OPG study]5.7885655
GSM549114patient 063, normal, homogenized [OPG study]5.6028752
GSM549122patient 082, normal, homogenized [OPG study]6.0041258
GSM549134patient 033, cancer, homogenized [OPG study]5.3471247
GSM549136patient 036, cancer, homogenized [OPG study]5.2610246
GSM549140patient 044, cancer, homogenized [OPG study]5.2054845
GSM549111patient 047, normal, homogenized [OPG study]5.5395551
GSM549113patient 057, normal, homogenized [OPG study]5.9303258
GSM549132patient 031, cancer, homogenized [OPG study]5.7232654
GSM549137patient 038, cancer, homogenized [OPG study]5.349647
GSM549142patient 047, cancer, homogenized [OPG study]5.984256
GSM549100patient 110, normal, homogenized [OPG study]5.5705851
GSM549107patient 135, normal, homogenized [OPG study]6.5090366
GSM549115patient 068, normal, homogenized [OPG study]5.5769752
GSM549116patient 072, normal, homogenized [OPG study]6.0602159
GSM549120patient 078, normal, homogenized [OPG study]6.3335463
GSM549131patient 030, cancer, homogenized [OPG study]5.6807854
GSM549118patient 074, normal, homogenized [OPG study]6.3523263
GSM549129patient 027, cancer, homogenized [OPG study]5.5825151
GSM549123patient 088, normal, homogenized [OPG study]5.900556
GSM549124patient 006, cancer, homogenized [OPG study]5.5123150
GSM549126patient 015, cancer, homogenized [OPG study]5.1868644
GSM549128patient 025, cancer, homogenized [OPG study]5.7303954
GSM549103patient 117, normal, homogenized [OPG study]6.3791764
GSM549117patient 073, normal, homogenized [OPG study]5.8001556
GSM549138patient 041, cancer, homogenized [OPG study]5.3728348
GSM549141patient 045, cancer, homogenized [OPG study]5.6024952
GSM549130patient 028, cancer, homogenized [OPG study]5.4772949
GSM549101patient 111, normal, homogenized [OPG study]5.6191751
GSM549105patient 128, normal, homogenized [OPG study]5.9036956
GSM549106patient 134, normal, homogenized [OPG study]5.8070856
GSM549112patient 048, normal, homogenized [OPG study]5.9804758
GSM549125patient 011, cancer, homogenized [OPG study]5.4461649
GSM549127patient 024, cancer, homogenized [OPG study]5.9198556
GSM549135patient 035, cancer, homogenized [OPG study]5.3739148